Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China flag China · Delayed Price · Currency is CNY
127.15
+1.15 (0.91%)
At close: May 28, 2026

SHE:301093 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
600.02616.04584.45621.9583.67819.27
Other Revenue
3.413.411.961.030.471.6
603.43619.45586.41622.92584.14820.87
Revenue Growth (YoY)
-0.33%5.63%-5.86%6.64%-28.84%83.92%
Cost of Revenue
372.6382363.66367.57334.13373.85
Gross Profit
230.83237.46222.76255.36250447.02
Selling, General & Admin
151141.32145.52145.13139.3141.4
Research & Development
41.0139.5139.5436.1836.6942.08
Other Operating Expenses
5.575.054.063.416.148.82
Operating Expenses
199.03187.35189.58183.67183.7194.68
Operating Income
31.850.1133.1871.6866.3252.34
Interest Expense
-1.74-1.35-0.25-0.44-0.6-4.83
Interest & Investment Income
8.428.9722.0548.214.893.74
Currency Exchange Gain (Loss)
1.871.87-2.811.951.40.72
Other Non Operating Income (Expenses)
-4.03-0.42-0.58-0.42-0.27-1.31
EBT Excluding Unusual Items
36.3359.1751.58120.9781.72250.66
Gain (Loss) on Sale of Investments
7.818.385.853.2625.83-
Gain (Loss) on Sale of Assets
-0.14-0.5400.210.27-0.02
Asset Writedown
0.42-0.03-0.05-0.04-0.84-
Other Unusual Items
3.612.151.1712.870.352.38
Pretax Income
48.0269.1358.55137.27107.33253.02
Income Tax Expense
6.249.278.9819.3413.5837
Earnings From Continuing Operations
41.7959.8649.57117.9393.75216.02
Minority Interest in Earnings
0.620.310---
Net Income
42.4160.1849.57117.9393.75216.02
Net Income to Common
42.4160.1849.57117.9393.75216.02
Net Income Growth
-25.96%21.39%-57.96%25.79%-56.60%165.52%
Shares Outstanding (Basic)
161164166175175139
Shares Outstanding (Diluted)
161164166177175139
Shares Change (YoY)
-2.44%-1.44%-5.92%0.98%26.34%5.62%
EPS (Basic)
0.260.370.300.670.541.56
EPS (Diluted)
0.260.370.300.670.541.56
EPS Growth
-24.11%23.15%-55.32%24.56%-65.65%151.39%
Free Cash Flow
-8.12-17.09-14.65-73.39-78.7392.78
Free Cash Flow Per Share
-0.05-0.10-0.09-0.41-0.450.67
Dividend Per Share
0.0500.0500.2000.4620.2310.538
Dividend Growth
-75.00%-75.00%-56.66%99.70%-57.08%-
Gross Margin
38.25%38.33%37.99%40.99%42.80%54.46%
Operating Margin
5.27%8.09%5.66%11.51%11.35%30.74%
Profit Margin
7.03%9.71%8.45%18.93%16.05%26.32%
Free Cash Flow Margin
-1.35%-2.76%-2.50%-11.78%-13.48%11.30%
EBITDA
100.86116.5589.15116.13101.15280.45
EBITDA Margin
16.71%18.82%15.20%18.64%17.32%34.16%
D&A For EBITDA
69.0666.4555.9844.4534.8428.11
EBIT
31.850.1133.1871.6866.3252.34
EBIT Margin
5.27%8.09%5.66%11.51%11.35%30.74%
Effective Tax Rate
12.99%13.41%15.33%14.09%12.65%14.62%
Revenue as Reported
603.43619.45586.41622.92584.14820.87
Advertising Expenses
-0.530.531.072.571.69
Source: S&P Global Market Intelligence. Standard template. Financial Sources.